Lymphoma (of) (malignant) C85.90 adult T-cell (HTLV-1-associated) (acute variant) (chronic variant) (lymphomatoid variant) (smouldering variant)
C91.5 Non-billable anaplastic large cell
ALK-negative
C84.7 Non-billable ALK-positive
C84.6 Non-billable breast implant associated (BIA-ALCL)
C84.7A CD30-positive
C84.6 Non-billable primary cutaneous
C86.6 Non-billable angioimmunoblastic T-cell
C86.5 Non-billable B-cell
C85.1 Non-billable B-precursor
C83.5 Non-billable blastic NK-cell
C86.4 Non-billable blastic plasmacytoid dendritic cell neoplasm (BPDCN)
C86.4 Non-billable brain, primary see Lymphoma, primary central nervous system
bronchial-associated lymphoid tissue [BALT-lymphoma]
C88.4 Non-billable Burkitt (atypical)
C83.7 Non-billable Burkitt-like
C83.7 Non-billable central nervous system, primary see Lymphoma, primary central nervous system
centrocytic
C83.1 Non-billable cutaneous follicle center
C82.6 Non-billable cutaneous T-cell
C84.A Non-billable diffuse follicle center
C82.5 Non-billable diffuse large cell
C83.3 Non-billable anaplastic
C83.3 Non-billable B-cell
C83.3 Non-billable CD30-positive
C83.3 Non-billable centroblastic
C83.3 Non-billable extranodal and solid organ sites NEC
C83.398 immunoblastic
C83.3 Non-billable plasmablastic
C83.3 Non-billable primary central nervous system (brain) (meninges) (PCNSL) (spinal cord)
C83.390 subtype not specified
C83.3 Non-billable T-cell rich
C83.3 Non-billable enteropathy-type (associated) (intestinal) T-cell
C86.2 Non-billable follicular
C82.9 Non-billable grade
specified NEC
C82.8 Non-billable hepatosplenic T-cell (alpha-beta) (gamma-delta)
C86.1 Non-billable histiocytic
C85.9 Non-billable Hodgkin
C81.9 Non-billable lymphocyte-rich (classical)
C81.4 Non-billable lymphocyte depleted (classical)
C81.3 Non-billable mixed cellularity (classical)
C81.2 Non-billable nodular sclerosis (classical)
C81.1 Non-billable specified NEC (classical)
C81.7 Non-billable lymphocyte-rich classical
C81.4 Non-billable lymphocyte depleted classical
C81.3 Non-billable mixed cellularity classical
C81.2 Non-billable nodular
lymphocyte predominant
C81.0 Non-billable sclerosis (classical)
C81.1 Non-billable intravascular large B-cell
C83.8 Non-billable Lennert's
C84.4 Non-billable lymphoblastic B-cell
C83.5 Non-billable lymphoblastic (diffuse)
C83.5 Non-billable lymphoblastic T-cell
C83.5 Non-billable lymphoepithelioid
C84.4 Non-billable lymphoplasmacytic
C83.0 Non-billable with IgM-production
C88.0 Non-billable mantle cell
C83.1 Non-billable mature T-cell NEC
C84.4 Non-billable mature T/NK-cell
C84.9 Non-billable specified NEC
C84.Z Non-billable Mediterranean
C88.3 Non-billable meninges, primary see Lymphoma, primary central nervous system
mucosa-associated lymphoid tissue [MALT-lymphoma]
C88.4 Non-billable NK/T cell
C84.9 Non-billable nodal marginal zone
C83.0 Non-billable non-follicular (diffuse)
C83.9 Non-billable specified NEC
C83.8 Non-billable non-Hodgkin
C85.9 Non-billable see also Lymphoma, by type specified NEC
C85.8 Non-billable non-leukemic variant of B-CLL
C83.0 Non-billable peripheral T-cell NEC
C84.4 Non-billable primary central nervous system (brain) (meninges) (PCNSL) (spinal cord)
C83.390 primary cutaneous
anaplastic large cell
C86.6 Non-billable CD30-positive large T-cell
C86.6 Non-billable primary effusion B-cell
C83.8 Non-billable skin-associated lymphoid tissue [SALT-lymphoma]
C88.4 Non-billable small cell B-cell
C83.0 Non-billable spinal cord, primary see Lymphoma, primary central nervous system
splenic marginal zone
C83.0 Non-billable subcutaneous panniculitis-like T-cell
C86.3 Non-billable T-precursor
C83.5 Non-billable